Li Hua Zheng
Founder at AnHeart Therapeutics (Hangzhou) Co., Ltd.
Li Hua Zheng active positions
| Companies | Position | Start | End |
|---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Director/Board Member | 27/11/2018 | - |
| Founder | 27/11/2018 | - | |
| Corporate Officer/Principal | 27/11/2018 | - | |
| Anbio, Inc. | Director/Board Member | 01/12/2017 | - |
| Founder | 01/12/2017 | - | |
| Zheng & Karg LLP | Corporate Officer/Principal | 01/01/2018 | - |
Career history of Li Hua Zheng
Former positions of Li Hua Zheng
| Companies | Position | Start | End |
|---|---|---|---|
| Liu, Zheng, Chen & Hoffman LLP | Corporate Officer/Principal | 01/10/2015 | 01/12/2017 |
| UCOMMUNE INTERNATIONAL LTD | Director/Board Member | 01/12/2018 | - |
| Independent Dir/Board Member | 01/12/2018 | - |
Training of Li Hua Zheng
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Graduate Degree |
| Fordham University School of Law | Graduate Degree |
Statistics
International
| United States | 7 |
| China | 3 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Graduate Degree | 2 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
Orisun Acquisition Corp.
 Orisun Acquisition Corp. Financial ConglomeratesFinance Orisun Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses. The company was founded on October 22, 2018 and is headquartered in New York, NY. | Finance |
| Anbio, Inc. | |
| Zheng & Karg LLP | |
| Liu, Zheng, Chen & Hoffman LLP |
- Stock Market
- Insiders
- Li Hua Zheng
- Experience
